Tributes were paid from all quarters following the death of Lord Lipsey at the age of 77 on Tuesday. David Lipsey, a former ...

Think You Have a 200%+ IQ? Put your vision and brainpower to the test with this thrilling optical illusion challenge! In this mind-bending puzzle, 25 popular movie objects are cleverly hidden within a ...

Additionally, the maturity dates of each of the Company’s three existing $10 million convertible notes payable to Mr. Uihlein and the aggregate borrowings of $81 million under several lines of credit, ...

Betting stakeholders have joined counterparts in greyhound racing in paying tribute to Lord David Lipsey, who passed away this week.

The Blues may have taken the title, but a Queenslander ruled the arena!New South Wales may have made history with their first-ever PBR Origin Series ...

NSW MAKES PBR ORIGIN HISTORY IN STUNNING SYDNEY DECIDER First-ever Series win sees NSW crush Queensland's undefeated streakFor the first time in PBR ...

Financial woes at ONE Championship have deepened into a full-blown crisis, with the promotion reporting a record consolidated ...

Our coffee morning at the Central Methodist Church in Launceston on June 3 was a great success again thanks to everyone who ...

Officials with Dallas Does Dance, a nonprofit organization dedicated to providing accessible dance education and performance ...

The inquiry into the Stuart Nash saga has been released – finding no other instances of sharing confidential information “other than those that led to his dismissal”, but it did reveal an ...

Gilead's top late-stage drug selonsertib, for patients with compensated cirrhosis due to nonalcoholic steatohepatitis (NASH), has failed a phase 3 trial. The drug, an apoptosis signal-regulating ...

Around this time last year, Akero was riding high on positive phase 2b data for its candidate non-alcoholic steatohepatitis (NASH) therapy, but new data has dented optimism about ...